×







We sell 100% Genuine & New Books only!

Malignant Tumors of the Lung Evidence based Management 1st Editon 2012 Softbound at Meripustak

Malignant Tumors of the Lung Evidence based Management 1st Editon 2012 Softbound by Jean-Paul Sculier, Willard A. Fry, Springer

Books from same Author: Jean-Paul Sculier, Willard A. Fry

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 6903.00/- [ 15.00% off ]

    Seller Price: ₹ 5868.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Jean-Paul Sculier, Willard A. Fry
    PublisherSpringer
    Edition1st Edition
    ISBN9783642622533
    Pages442
    BindingSoftbound
    LanguageEnglish
    Publish YearOctober 2012

    Description

    Springer Malignant Tumors of the Lung Evidence based Management 1st Editon 2012 Softbound by Jean-Paul Sculier, Willard A. Fry

    Lung cancer is the neoplastic disease with the highest mortality numbers in the world. The disease is very common in industrialized countries. This textbook synthesizes the basic science of lung cancer with state-of-the-art accounts of diagnosis and treatment. Written by a distinguished panel of experts from Europe, Asia, and North America, it covers all of the most important fields: biology, pathology, epidemiology, screening, diagnosis, therapy, supportive care, and prognosis. All physicians caring for patients with lung cancer, especially surgeons, chest physicians, radiation oncologists, and medical oncologists, will find a wealth of information that meets their needs. Whenever possible, the principles of evidence-based medicine are followed by providing data from systematic reviews, meta-analyses, methodology-based guidelines, and randomized clinical trials. Epidemiology, biology and pathology.- Molecular and Cell Biology of Lung Carcinoma.- Clinically Useful Biomarkers.- Pathology of Lung Cancer.- The Epidemiology of Lung Cancer.- Lung Cancer and Tobacco: Historical Issues, Epidemiology, and Intervention.- Professional Risks and Environmental Factors.- Early Detection, Diagnosis and Staging.- Radiologic Screening for Lung Cancer.- Lung Cancer Screening: the Role of Bronchoscopy.- Clinical Presentation of Lung Cancer.- Differential Diagnosis.- Imaging.- PET Scan.- Pathological Diagnosis.- Mediastinal Staging.- Assessment of Operability and Resectability in Lung Cancer.- TNM Staging.- Treatment Non-Small Cell Lung Cancer.- Surgery for Non-Small Cell Lung Cancer.- Neoadjuvant Treatments in Resectable Non-Small Cell Lung Cancer.- Adjuvant Treatments in Resectable NSCLC.- Exclusive Radiotherapy.- Combined Modality Therapy for Unresectable Non-Small Cell Lung Cancer.- Chemotherapy for Advanced Non-Small Cell Lung Cancer.- Salvage Therapy in Non-Small Cell Lung Cancer.- Small Cell Lung Cancer.- Small Cell Lung Cancer: Limited Disease.- Small Cell Lung Cancer: Treatment for Extensive Stage Disease.- Surgery for Small Cell Lung Cancer.- Prophylactic Cranial Irradiation.- Salvage Therapy in Small Cell Lung Cancer.- Other Treatments.- Endoscopic Treatments.- Biological Treatments for Lung Cancer.- Complications and Supportive Care.- Bone Marrow Aplasia.- Management of Superior Vena Cava Syndrome.- Complications and Supportive Care: Airway Obstruction.- Malignant Pleural Effusion.- Symptomatic Treatment in Lung Cancer.- End-of-Life Care in Patients with Lung Cancer.- Prognostic Factors in Non-Small Cell Lung Cancer.- SCLC-Prognosis.



    Book Successfully Added To Your Cart